India to Mauritius: Empagliflozin Export Trade Route

The India to Mauritius Empagliflozin corridor is one of India's established pharmaceutical export routes, with 839 shipments documented worth a combined $1.7M USD. The route is dominated by HEXA HEALTH CARE PRIVATE LIMITED, which alone accounts for roughly 41% of all export value, reflecting the consolidated nature of India's empagliflozin manufacturing sector.

Across 12 active suppliers, the average shipment value stands at $2.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with empagliflozin's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 12.9%, placing it at rank #8 among India's top empagliflozin export destinations globally.

On the import side, key buyers of Indian empagliflozin in Mauritius include REGENCY PHARMA LIMITED, REGENCY PHARMA LTD, ZAPATERO INTERNATIONAL LTD and 10 others. REGENCY PHARMA LIMITED is the single largest importer with 590 shipments valued at $1.0M USD.

India's empagliflozin exports to Mauritius are driven primarily by a handful of large-scale manufacturers. HEXA HEALTH CARE PRIVATE LIMITED with 113 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in Mauritius benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — HEXA HEALTH CARE PRIVATE LIMITED, SAVA HEALTHCARE LIMITED, PLEASANT EXPORTS — together account for 90% of total trade value on this route. The average shipment value of $2.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as jardiance 10 mg 90 tab empagliflozin and jardiance 25mg 90 tab empagliflozin, suggesting that buyers in Mauritius tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, REGENCY PHARMA LIMITED is the largest importer with 590 shipments worth $1.0M USD — representing 61% of all empagliflozin imports from India on this route. A total of 13 buyers are active on this corridor.